Since SKCM has shown a good response to cancer immunotherapy and the immune implication of the SIT1 gene in SKCM remains mostly unknown so far, we systematically elucidate the association between SIT1 and SKCM immunity as well as the SIT1-mediated immune response-associated signaling pathways. The gene discussed is SIT1; the disease is cancer.